Medley Genomics looks to engineer cancer treatment, one tumor at a time

Susan Shalhoub

09/28/2018

ACTIONABLE DATA: From left, Niru Chennagiri, director of informatics at Medley Genomics, and Patrice Milos, CEO, review notes on genetic information at the company’s Providence office.   / PBN PHOTO/RUPERT WHITELEY

Innovative Companies | Biotechnology and Life Sciences We’ve all heard of data analytics. But what if this data could be used to treat what may well be the biggest medical beast of our time, cancer? Looking at tumors’ unique, individual composition to find information leading to lasting treatment is the work of Medley Genomics of…

Register to keep reading or subscribe today and receive unlimited access.
Already a Subscriber?

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.